Orthofix Medical Inc.
OFIX
$12.00
-$0.49-3.92%
NASDAQ
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Revenue | 193.65M | 215.66M | 196.61M | 198.62M | 188.61M |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 193.65M | 215.66M | 196.61M | 198.62M | 188.61M |
| Cost of Revenue | 72.03M | 63.77M | 61.55M | 63.87M | 61.37M |
| Gross Profit | 121.62M | 151.89M | 135.05M | 134.75M | 127.24M |
| SG&A Expenses | 132.98M | 136.48M | 130.14M | 134.22M | 131.69M |
| Depreciation & Amortization | 3.04M | 4.34M | 4.55M | 4.32M | 6.57M |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 227.81M | 223.40M | 213.54M | 220.46M | 219.12M |
| Operating Income | -34.17M | -7.74M | -16.93M | -21.84M | -30.51M |
| Income Before Tax | -52.13M | -29.71M | -26.64M | -32.36M | -35.17M |
| Income Tax Expenses | 961.00K | -564.00K | 751.00K | 1.08M | 851.00K |
| Earnings from Continuing Operations | -53.09M | -29.15M | -27.39M | -33.44M | -36.02M |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -53.09M | -29.15M | -27.39M | -33.44M | -36.02M |
| EBIT | -34.17M | -7.74M | -16.93M | -21.84M | -30.51M |
| EBITDA | 1.52M | 19.55M | -141.00K | -6.30M | -14.17M |
| EPS Basic | -1.35 | -0.75 | -0.71 | -0.88 | -0.95 |
| Normalized Basic EPS | -0.60 | -0.41 | -0.40 | -0.48 | -0.60 |
| EPS Diluted | -1.35 | -0.75 | -0.71 | -0.88 | -0.95 |
| Normalized Diluted EPS | -0.60 | -0.41 | -0.40 | -0.48 | -0.60 |
| Average Basic Shares Outstanding | 39.19M | 38.70M | 38.49M | 38.02M | 37.74M |
| Average Diluted Shares Outstanding | 39.19M | 38.70M | 38.49M | 38.02M | 37.74M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |